USA TODAYUh-oh! CRISPR gene-editing stocks may be worthlessUSA TODAYThe big-ticket item is that this journal article reported that most humans probably have pre-existing immune defenses against the "cutting element" in CRISPR known as Cas9. … Continue reading
|
New biomarkers predict outcome of cancer immunotherapy
EurekAlert (press release) Nowadays, melanoma and lung cancer can be combatted effectively through immunotherapy, which makes targeted use of the immune system’s normal function of regularly examining the body’s tissue for pathogens and damages. Specific inhibitors are used to … |
|
New biomarkers predict outcome of cancer immunotherapy
EurekAlert (press release) Nowadays, melanoma and lung cancer can be combatted effectively through immunotherapy, which makes targeted use of the immune system’s normal function of regularly examining the body’s tissue for pathogens and damages. Specific inhibitors are used to … |
|
Renew Biopharma Launches Pre-Clinical Drug Discovery Program with Indiana University Bloomington’s Gill Center …
Business Wire (press release) Dr. Mackie said: “I couldn’t be more excited to work with a synthetic biology company like Renew because they can deliver conventional and novel cannabinoid molecules in amounts and purity for potential human therapeutics in a completely new and … |
Lab Manager Magazine |
Mechanism for Resistance to Immunotherapy Treatment Discovered
Lab Manager Magazine An urgent question for cancer scientists is why immunotherapy achieves dramatic results in some cases but doesn’t help most patients. Now, two research groups from Dana-Farber Cancer Institute have independently discovered a genetic mechanism in cancer … |
Lab Manager Magazine |
Mechanism for Resistance to Immunotherapy Treatment Discovered
Lab Manager Magazine An urgent question for cancer scientists is why immunotherapy achieves dramatic results in some cases but doesn’t help most patients. Now, two research groups from Dana-Farber Cancer Institute have independently discovered a genetic mechanism in cancer … |